• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Rabbit anti-Human Phospho-TIFA-T9 Monoclonal Antibody

The antibody against Phospho-TIFA-T9 was raised in Rabbit using a synthetic phosphorylated peptide around T9 of human TIFA(NP_443096.1) as the immunogen. The monoclonal antibody exists as a isotype IgG, by affinity purification. This antibody has been validated on WB, ELISA.

ADA-15716A

The antibody against Phospho-TIFA-T9 was raised in Rabbit using a synthetic phosphorylated peptide around T9 of human TIFA(NP_443096.1) as the immunogen. The monoclonal antibody exists as a isotype IgG, by affinity purification. This antibody has been validated on WB, ELISA.

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ADA-15716A ClonalityMonoclonal
Host SpeciesRabbitTarget NamePhospho-TIFA-T9
Target SynonymsT2BP; T6BP; TIFAA; Phospho-TIFA-T9FormLiquid
Species ReactivityHumanIsotypeIgG
Storage Buffer50% Glycerol, 0.05% BSA, PBS with 0.05% proclin300, pH7.3.Purification MethodAffinity purification
Positive Samples293T+AgonistApplicationELISA, WB

Immunogen Information


Immunogen DescriptionA synthetic phosphorylated peptide around T9 of human TIFA(NP_443096.1).Target SpeciesHuman
Immunogen SequenceADTEEUniprot IDQ96CG3
Background Information
  • Uniprot Id

    Q96CG3

  • Target Species

    Human

  • Target Name

    TIFA

  • Target Full Name

    TRAF-interacting protein with FHA domain-containing protein A

  • Target Function

    Adapter molecule that plays a key role in the activation of proinflammatory NF-kappa-B signaling following detection of bacterial pathogen-associated molecular pattern metabolites (PAMPs). Promotes activation of an innate immune response by inducing the oligomerization and polyubiquitination of TRAF6, which leads to the activation of TAK1 and IKK through a proteasome-independent mechanism. TIFA-dependent innate immune response is triggered by ADP-D-glycero-beta-D-manno-heptose (ADP-Heptose), a potent PAMP present in all Gram-negative and some Gram-positive bacteria: ADP-Heptose is recognized by ALPK1, which phosphorylates TIFA at Thr-9, leading to TIFA homooligomerization and subsequent activation of proinflammatory NF-kappa-B signaling.

  • Target Subcellular Location

    Cytoplasm.

  • Target Synonyms

    Putative MAPK activating protein PM14; Putative MAPK-activating protein PM14; Putative NF kappa B activating protein 20; Putative NF-kappa-B-activating protein 20; T2BP; TIFA; TIFA_HUMAN; TRAF interacting protein with FHA domain containing protein A; TRAF-interacting protein with FHA domain-containing protein A; TRAF2 binding protein; TRAF2-binding protein

  • Target Background

    This gene encodes an adapter protein involved in adaptive and innate immunity. This protein includes a forkhead-associated (FHA) domain that specifically binds to phosphorylated serine and threonine residues. In response to bacterial infection, the encoded host cell protein undergoes an intermolecular interaction between the FHA domain and a phosphorylated threonine that leads to protein oligomerization and stimulation of the NF-kappa B and other downstream signaling pathways. This protein exhibits reduced expression in hepatocellular carcinoma and may suppress hepatocellular carcinoma progression. This protein may also play a role in the DNA damage response.

Inquire Rabbit anti-Human Phospho-TIFA-T9 Monoclonal Antibody Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification